Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Patterson

Showing results (201-210 of 277) with videos related to

Pageof 28
Sort By:
Molecular Cancer Therapeutics|October 14, 2003
Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenograftsRachel L Cowen, Adam V Patterson, Brian A Telfer, et al.
Cancer Gene Therapy|November 3, 2007
The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411(NTR)D C Singleton, D Li, S Y Bai, et al.
Journal of Medicinal Chemistry|October 24, 2022
Design, Synthesis, and Biological Evaluation of 5-Formyl-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamides as New Selective, Potent, and Reversible-Covalent FGFR4 InhibitorsFang Yang, Xiaojuan Chen, Xiaojuan Song, et al.
Molecular Cancer Therapeutics|October 8, 2009
Nitro-chloromethylbenzindolines: hypoxia-activated prodrugs of potent adenine N3 DNA minor groove alkylatorsWilliam R Wilson, Stephen M Stribbling, Frederik B Pruijn, et al.
Urology|September 17, 2017
Development of a Natural Language Processing Engine to Generate Bladder Cancer Pathology Data for Health Services ResearchFlorian R Schroeck, Olga V Patterson, Patrick R Alba, et al.
Bioorganic & Medicinal Chemistry|January 18, 2014
Synthesis and cytotoxicity of pyranonaphthoquinone natural product analogues under bioreductive conditionsAmanda M Heapy, Adam V Patterson, Jeff B Smaill, et al.
Urology|September 4, 2016
Early Stage Bladder Cancer: Do Pathology Reports Tell Us What We Need to Know?Florian R Schroeck, Erik A Pattison, Daniel W Denhalter, et al.
Journal of Medicinal Chemistry|December 28, 2002
Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamineMichael P Hay, Swarna A Gamage, Mary S Kovacs, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2010
Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in miceYongchuan Gu, Christopher P Guise, Kashyap Patel, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) InhibitorsCheng Mo, Zhang Zhang, Christopher P Guise, et al.
Pageof 28

Showing results (201-210 of 277) with videos related to

Sort By:
Pageof 28
Molecular Cancer Therapeutics|October 14, 2003
Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenograftsRachel L Cowen, Adam V Patterson, Brian A Telfer, et al.
Cancer Gene Therapy|November 3, 2007
The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411(NTR)D C Singleton, D Li, S Y Bai, et al.
Journal of Medicinal Chemistry|October 24, 2022
Design, Synthesis, and Biological Evaluation of 5-Formyl-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamides as New Selective, Potent, and Reversible-Covalent FGFR4 InhibitorsFang Yang, Xiaojuan Chen, Xiaojuan Song, et al.
Molecular Cancer Therapeutics|October 8, 2009
Nitro-chloromethylbenzindolines: hypoxia-activated prodrugs of potent adenine N3 DNA minor groove alkylatorsWilliam R Wilson, Stephen M Stribbling, Frederik B Pruijn, et al.
Urology|September 17, 2017
Development of a Natural Language Processing Engine to Generate Bladder Cancer Pathology Data for Health Services ResearchFlorian R Schroeck, Olga V Patterson, Patrick R Alba, et al.
Bioorganic & Medicinal Chemistry|January 18, 2014
Synthesis and cytotoxicity of pyranonaphthoquinone natural product analogues under bioreductive conditionsAmanda M Heapy, Adam V Patterson, Jeff B Smaill, et al.
Urology|September 4, 2016
Early Stage Bladder Cancer: Do Pathology Reports Tell Us What We Need to Know?Florian R Schroeck, Erik A Pattison, Daniel W Denhalter, et al.
Journal of Medicinal Chemistry|December 28, 2002
Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamineMichael P Hay, Swarna A Gamage, Mary S Kovacs, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2010
Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in miceYongchuan Gu, Christopher P Guise, Kashyap Patel, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) InhibitorsCheng Mo, Zhang Zhang, Christopher P Guise, et al.
Pageof 28